Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer

British Journal of Cancer

Volumn 77, Issue 6, 1998, Pages 917-925

  Palmqvist, R ^a   Oberg A ^a   Bergstrom C ^a   Rutegard J N ^a,b   Zackrisson, B ^a   Stenling, R ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Örnsköldsviks Hospital   (Sweden)

Author keywords

Cell proliferation; Colorectal carcinoma; Flow cytometry; Heterogeneity; Immunohistochemistry; Iododeoxyuridine

Indexed keywords

IDOXURIDINE;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL LABELING; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR CELL;

EID: 0031889124     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.152     Document Type: Article

References (52)

1. Al-Sheneber IF, Shibata HR, Sampalis J and Jothy S (1993) Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 71: 1954-1959
2. Baretton GB, Diebold J, Christoforis G, Vogt M, Muller C, Dopfer K, Schneiderbanger K, Schmidt M and Lohrs U (1996) Apoptosis and immunohistochemical bel-2 expression in colorectal adenomas and carcinomas -aspects of carcinogenesis and prognostic significance. Cancer 77: 255-264
3. Bauer KD, Lincoln ST, Vera Roman JM, Wallemark CB, Chmiel JS, Madurski ML, Murad T and Scarpelli DG (1987) Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. Lab Invest 57: 329-335
4. Bauer KD, Bagwell CB, Giaretti W, Melamed M, Zarbo RJ, Witzig TE and Rabinovitch PS (1993) Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 14: 486-491
5. Begg AC, McNally NJ, Shrieve DC and Karcher H (1985) A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626
6. Bennett MH, Wilson GD, Dische S, Saunders MI, Martindale CA, Robinson BM, O'Halloran AE, Leslie MD and Laing JH (1992) Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 65: 870-878
7. Dische S and Saunders MI (1989) Continuous, hyperfractionated, accelerated radiotherapy (CHART). Br J Cancer 59: 325-326
8. Enker WE, Kimmel M, Cibas KS, Cranor ML and Melamed MR (1991) DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival. J Natl Cancer Inst 83: 701-707
9. Gamel JW, Meyer JS and Province MA (1995) Proliferative rate by S-phase measurement may affect cure of breast carcinoma. Cancer 76: 1009-1018
10. Gundersen HJG (1977) Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J Microsc 111: 219-223
11. Gundersen HJG and Osterby R (1981) Optimizing sampling efficiency of stereological studies in biology: or 'Do more less well!'. J Microsc 121: 65-73
12. Gundersen HJG and Jensen EB (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147: 229-263
13. Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A and West MJ (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 96: 379-394
14. Harlow SP, Eriksen BL, Poggensee L, Chmiel JS, Scarpelli DG, Murad T and Bauer KD (1991) Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas. Cancer Res 51: 2403-2409
15. Hiddemann W, Von Bassewitz DB, Kleinemeier HJ, Schulte Brochterbeck E, Hauss J, Lingemann B, Buchner T and Grundmann E (1986) DNA stemline heterogeneity in colorectal cancer. Cancer 58: 258-263
16. Holm T, Cedermark B and Rutqvist LE (1994) Local recurrence of rectal adenocarcinoma alter 'curative' surgery with and without preoperative radiotherapy. Br J Surg 81: 452-455
17. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) Investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939-944
18. Jass JR, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM and Todd IP (1986) The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 10: 437-459
19. Koha M, Caspersson TO, Wikstrom B and Brismar B (1990) Heterogeneity of DNA distribution pattern in colorectal carcinoma. A microspectrophotometric study of fine needle aspirates. Anal Quant Cytol Histol 12: 348-351
20. Koochekpour S, Merzak A and Pilkington GJ (1995) Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer 31: 375-380
21. Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbs RR and Fazio VW (1992) Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 70: 2602-2609
22. Larsson P, Roos G, Stenling R and Ljungberg B (1994) Proliferation of human renal cell carcinoma studied with in vivo iododeoxyuridine labelling and immunohistochemistry. Scand J Urol Nephrol 28: 135-140
23. Lawrence DA (1996) Transforming growth factor-beta: a general review. Eur Cytokine Netw 7: 363-374
24. Lindmark G, Glimelius B, Pahlman L and Enblad P (1991) Heterogeneity in ploidy and S-phase fraction in colorectal adenocarcinomas. Int J Colorectal Dis 6: 115-120
25. Lochrin CA, Wilson GD, McNally NJ, Dische S and Saunders MI (1992) Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int J Radiat Oncol Biol Phys 24: 87-91
26. Macfarlane JK, Ryall RD and Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341: 457-460
27. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH and Maillard JA (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122: 321-326
28. Mullan FJ, Wilson HK, Majury CW, Mills JO, Cromie AJ, Campbell GR and McKelvey ST (1990) Bile acids and the increased risk of colorectal tumours after truncal vagotomy. Br J Surgery 77: 1085-1090
29. Nylander K, Anneroth G, Gustafsson H, Roos G, Stenling R and Zackrisson B (1994) Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications. Acta Oncol 33: 23-28
30. Paradiso A, Rabinovich M, Vallejo C, Machiavelli M, Romero A, Perez J, Lacava J, Cuevas MA, Rodriquez R, Leone B, Sapia MG, Simone G and De Lena M (1996) p53 and PCNA expression in advanced colorectal cancer: Response to chemotherapy and long-term prognosis. Int J Cancer 69: 437-441
31. Pilkington GJ (1992) Glioma heterogeneity in vitro: the significance of growth factors and gangliosides. Neuropathol Appl Neurobiol 18: 434-442
32. Quirke P, Dyson JED, Dixon MF, Bird CC and Joslin CAF (1985) Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br J Cancer 51: 99-106
33. Row DA (1993) Cell proliferation, tumour growth and clinical outcome: gains and losses in intestinal cancer. Ann R Coll Surg Engl 75: 397-404
34. Rew DA, Wilson GD, Taylor I and Weaver PC (1991) Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg 78: 60-66
35. Riccardi A, Giordano M, Danova M, Girino M, Brugnatelli S, Ucci G and Mazzini G (1991) Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non-lymphoblastic leukaemia. Eur J Cancer 27: 882-887
36. Riethmuller G, Schneider Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggish P, Witte J and The German Cancer Aid 17-1A Study Group (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343: 1177-1183
37. Scott NA, Grande JP, Weiland LH, Pemberton JH, Beart Jr RW and Lieber MM (1987) Flow cytometric DNA patterns from colorectal cancers - how reproducible are they? Mayo Clin Proc 62: 331-337
38. Shepherd NA, Richman PI and England J (1988) Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol 155: 213-219
39. Steel GG (1977) Growth kinetics of tumours. Clarendon Press: Oxford.
40. Taniyama K, Suzuki H, Matsumoto M, Hakamada K, Toyama K and Tahara E (1993) Relationships between nodal status and cell kinetics, DNA ploidy pattern and histopathology of the deeply infiltrating sites in colorectal adenocarcinoma. Acta Pathol Jpn 43: 590-596
41. Taniyama K, Sasaki N, Wada S, Sasaki M, Miyoshi N, Nakai H, Kodama S, Nakatsuka H and Tahara E (1996) Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas. Pathology International 46: 195-203
42. Teixeira CR, Tanaka S, Haruma K, Yoshihara M, Sumii K and Kajiyama G (1994) Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas. Cancer 73: 575-579
43. Terry NH, Meistrich ML, Roubein LD, Lynch PM, Dubrow RA and Rich TA (1995) Cellular kinetics in rectal cancer. Br J Cancer 72: 435-441
44. Thorgeirsson UP, Turpeenniemi Hujanen T, Neckers LM, Johnson DW and Liotta LA (1984) Protein synthesis but not DNA synthesis is required for tumor cell invasion in vitro. Invasion Metastasis 4: 73-83
45. Vermeulen PB, Verhoeven D, Hubens G, Van Marck E, Goovaerts G, Huyghe M, De Bruijn EA, Van Oosterom AT and Dirix LY (1995) Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann Oncol 6: 59-64
46. Weibel ER (1979) Practical methods for biological morphometry. Academic Press: London
47. West MJ and Gundersen HJ (1990) Unbiased stereological estimation of the number of neurons in the human hippcampus. J Comp Neurol 296: 1-22
48. Wilson GD (1991) Assessment of human tumour proliferation using bromodeoxyuridine - current status. Acta Oncol 30: 903-910
49. Wilson GD and McNally MC (1992) Measurement of cell proliferation using bromodeoxyuridine. In Assessment of Cell Proliferation in Clinical Practice. Hall PA, (ed.), pp. 113-139, Springer: London
50. pdt) in human colorectal cancers. Br J Cancer 67: 754-759
51. pdt) in colorectal cancer. Br J Cancer 68: 501-506
52. Witzig TE, Loprinzi CL, Gonchoroff NJ, Reiman HM, Cha SS, Wieand HS, Katzmann JA, Paulsen JK and Moertel CG (1991) DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer 68: 879-888